Summary:
Click image to enlargeA PHASE 1/2 RANDOMIZED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A MODIFIED RNA VACCINE AGAINST INFLUENZA IN HEALTHY INDIVIDUALS
Qualified Participants Must:
Must be 65 to 85 years old
Must have received a flu vaccine more than 120 days ago
Be generally healthy
Cannot have heart issues or autoimmune disorders